...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Zenith trial partners

please, you post your debbie downer/karen crap so don't try & flip it - your no different than little john far as i can tell.

did you get out today , you were going to be "gobsmack" at a .20 buy out - take a hike or put on ignore.

thats your post mr gobsmack - deal with it & choke on your .20 cheap bti shares you thanked people for giving you while your at it.

there your posts , not mine karenĀ 

Share
New Message
Please login to post a reply